Cambridge Crossing Lab Tower Refinanced for $341M
Cambridge Crossing developer DivcoWest refinanced its newest lab tower at Cambridge Crossing with $341.3 million from KKR.
Cambridge Crossing developer DivcoWest refinanced its newest lab tower at Cambridge Crossing with $341.3 million from KKR.
Boston-based Synergy recapitalized a Beacon Hill office building Friday that it originally acquired in 2013 in a deal worth $23 million.
DivcoWest made its second big Boston office acquisition of 2025 with the $125 million purchase of a 245,000 square-foot Back Bay tower.
When close to 1,000 HarbourVest employees head to the office, they have access to an amenities package worthy of a luxury condominium tower.
The new owners of Boston’s One Lincoln office tower are seeking to accomplish what prior owner Fortis Property Group could not: attract tenants to fill the void left behind by the departure of State Street Corp. and downsizing by WeWork.
Lenders postponed an auction of Boston’s One Lincoln office tower at the last minute, delaying a potential change of ownership for the 1.1 million-square-foot skyscraper.
Lenders scheduled a real estate auction for the 1.1 million-square-foot One Lincoln tower in Boston, in the biggest example of fallout from the downtown office market’s post-pandemic distress.
Federal Realty Investment Trust is delaying groundbreaking of a 381,529-square-foot life science project at Somerville’s Assembly Row, citing “oversaturation” in the lab development market.
The developer of a delayed West Roxbury apartment complex claims that its general contractor engaged in “rampant misconduct” by withholding over $2.2 million in payments to subcontractors.
The developer of a 19-story lab tower in Somerville’s Assembly Square is seeking an extension to redesign the project following a change of ownership and continuing sluggishness in life science leasing.
As life science companies retreat to established industry clusters in 2023, a new East Cambridge project landed a 62,000-square-foot lease for a new office, lab and incubator space.
A West Roxbury commercial property will be redeveloped as a 70-unit apartment complex with sustainable features by Boston-based RISE in partnership with DivcoWest.
The saga of Parcel Q2 at DivcoWest’s mega-development on the fringes of East Cambridge is continuing with a second use change proposed for the site.
Using data from brokerages Newmark, JLL and Colliers International, plus information from tenant and landlord SEC filings and earnings presentations, Banker & Tradesman has compiled a look at who dominates some of the most active life science submarkets and what’s in the pipeline.
Construction crews topped off the first residential building built at Cambridge Crossing under DivcoWest’s ownership, a 468-unit tower known as Park 151.
DicvoWest is beginning construction of a speculative 375,000-square-foot lab building at Cambridge Crossing to meet potential life science tenants’ space needs in early 2023.
Lamplighter Brewing Co. will open a tap room and production space at Cambridge Crossing this summer after revising plans in the wake of the pandemic.
With an additional 113,000-square-foot commitment, Bristol Myers Squibb has spoken for all of the office-lab space in DivcoWest’s 250 Water St. development at Cambridge Crossing.
John Moriarty and Assoc. and Consigli Construction have completed the framing work at 350 and 450 Water St. at DivcoWest’s 4.5 million-square-foot Cambridge Crossing development.
Construction crews marked a milestone in the development of Sanofi’s new U.S. research headquarters that will house 3,000 employees at Cambridge Crossing.